Products Categories
CAS No.: | 125-52-0 |
---|---|
Name: | OXYPHENCYCLIMINE |
Molecular Structure: | |
Formula: | C20H28N2O3·ClH |
Molecular Weight: | 380.91 |
Synonyms: | benzeneacetic acid, α-cyclohexyl-α-hydroxy-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, hydrochloride (1:1);Syklifen;Ulcociclinina;Vio-Thene;Benzeneaceticacid, a-cyclohexyl-a-hydroxy-,(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, monohydrochloride(9CI);Cyclohexaneglycolic acid, a-phenyl-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl estermonohydrochloride (8CI);(1-Methyl-1,4,5,6-tetrahydro-2-pyrimidyl)methyl a-cyclohexyl-a-phenylglycolate hydrochloride;Daricol;Daricon;Dominil;Enterex;NSC 528449;Oximin; |
EINECS: | 204-742-8 |
Density: | 1.18g/cm3 |
Boiling Point: | 528.2 °C at 760 mmHg |
Flash Point: | 273.2 °C |
Hazard Symbols: | Xn |
Risk Codes: | 20/21/22 |
Safety: | 36 |
PSA: | 62.13000 |
LogP: | 2.90720 |
The Oxyphencyclimine hydrochloride, with the CAS registry number 125-52-0, is also known as Benzeneacetic acid, α-cyclohexyl-α-hydroxy-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, hydrochloride (1:1). Its EINECS number is 204-343-9. This chemical's molecular formula is C20H28N2O3·ClH and molecular weight is 380.91. What's more, its systematic name is (1-Methyl-1,4,5,6-tetrahydro-2-pyrimidinyl)methyl cyclohexyl(hydroxy)phenylacetate hydrochloride (1:1). Its classification code is Drug / Therapeutic Agent.
Physical properties of Oxyphencyclimine hydrochloride are: (1)ACD/LogP: 4.687; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2.69; (4)ACD/LogD (pH 7.4): 2.70; (5)ACD/BCF (pH 5.5): 21.48; (6)ACD/BCF (pH 7.4): 22.13; (7)ACD/KOC (pH 5.5): 84.49; (8)ACD/KOC (pH 7.4): 87.03; (9)#H bond acceptors: 5; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 7; (12)Polar Surface Area: 51.13 Å2; (13)Flash Point: 273.2 °C; (14)Enthalpy of Vaporization: 84.52 kJ/mol; (15)Boiling Point: 528.2 °C at 760 mmHg; (16)Vapour Pressure: 5.52E-12 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
This chemical is harmful by inhalation, in contact with skin and if swallowed. When using it, you need wear suitable protective clothing.
You can still convert the following datas into molecular structure:
(1)SMILES: Cl.O=C(OCC/1=N/CCCN\1C)C(O)(c2ccccc2)C3CCCCC3
(2)Std. InChI: InChI=1S/C20H28N2O3.ClH/c1-22-14-8-13-21-18(22)15-25-19(23)20(24,16-9-4-2-5-10-16)17-11-6-3-7-12-17;/h2,4-5,9-10,17,24H,3,6-8,11-15H2,1H3;1H
(3)Std. InChIKey: WXAYTPABEADAAB-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 47mg/kg (47mg/kg) | CARDIAC: CHANGE IN RATE SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: TREMOR | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
dog | LD50 | oral | 1gm/kg (1000mg/kg) | BEHAVIORAL: TREMOR CARDIAC: CHANGE IN RATE SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
mouse | LD50 | intramuscular | 210mg/kg (210mg/kg) | BEHAVIORAL: ATAXIA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
mouse | LD50 | intraperitoneal | 130mg/kg (130mg/kg) | BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
mouse | LD50 | intravenous | 80mg/kg (80mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: ATAXIA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
mouse | LD50 | oral | 860mg/kg (860mg/kg) | Drugs in Japan Vol. 6, Pg. 152, 1982. | |
mouse | LD50 | subcutaneous | 335mg/kg (335mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
rat | LD50 | intramuscular | 1050mg/kg (1050mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
rat | LD50 | intraperitoneal | 130mg/kg (130mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: ATAXIA | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
rat | LD50 | intravenous | 88mg/kg (88mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: ATAXIA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |
rat | LD50 | oral | 1370mg/kg (1370mg/kg) | Drugs in Japan Vol. 6, Pg. 152, 1982. | |
rat | LD50 | subcutaneous | 1150mg/kg (1150mg/kg) | BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Toxicology and Applied Pharmacology. Vol. 1, Pg. 391, 1959. |